Microlife Microlife
  • Prodotti Domiciliari
    • BP A6 Advanced Easy_red_logo Pressione arteriosa
    • trasp_NON CONTACT Febbre
    • trasp_NEB NANO_half-acc_PRINT_LOcopy1 Terapia respiratoria
    • trasp_WS 80n_half Controllo del peso
    • Software_downloads_allg Software
  • Prodotti Professionali
    • WatchBP Office ABI_front_cuff WatchBP Office
    • WatchBP O3 Ambulatory AFIB_front_cuff WatchBP 03
    • WatchBP Home A_front_cuff WatchBP Home
    • Cuff-Ankle Bracciali e Accessori
    • Software Software
  • Tecnologie
  • Magazine
  • Azienda
    • aboutus Chi siamo
    • Events Eventi e News
    • contact Contatti
    • History Storia
ITALIA
Italiano
Europe
  • EUROPE - English
  • CZECHIA - Čeština
  • DANMARK - Dansk
  • DEUTSCHLAND - Deutsch
  • ESPAÑA - Español
  • FRANCE - Français
  • HRVATSKA - Hrvatski
  • ITALIA - Italiano
  • LATVIJA - Latviešu
  • LIETUVA - Lietuvių
  • MAGYARORSZÁG - Magyar
  • NEDERLAND - Nederlands
  • ÖSTERREICH - Deutsch
  • POLSKA - Polski
  • PORTUGAL - Português
  • SCHWEIZ - Deutsch
  • SLOVENSKO - Slovenčina
  • SLOVENIJA - Slovenščina
  • SUOMI - Suomi
  • SCHWEIZ - Français
  • UK - English
  • ΕΛΛΆΔΑ - Ελληνικά
  • БЪЛГАРИЯ - Български
  • СРБИЈА - Српски
  • УКРАЇНА - Українська
  • TÜRKIYE - Türkçe
  • РОССИЯ - Русский
  • БЕЛАРУСЬ - Русский
Asia
  • ASIA PACIFIC - English
  • VIỆT NAM - Tiếng Việt
  • ประเทศไทย - ไทย
  • 中国 - 中文
  • 台灣 - 中文
Middle East and North Africa
  • MENA - Arabic عربى
USA, Latin America
  • US - English
  • AMÉRICA DEL SUR - Español
  • COLOMBIA - Español
  • MÉXICO - Español
Menu
Header Microlife & WatchBP Clinical Studies Flow

Detection of atrial fibrillation using a modified Microlife blood pressure monitor

Home > Prodotti Professionali
Share

2009, Joseph Wiesel1, Lorenzo Fitzig1, Yehuda Herschman2 and Frank C. Messineo1

Abstract

Background
Hypertension is a major risk factor for the development of atrial fibrillation (AF) and for stroke due to AF. Asymptomatic AF can result in a stroke, in patients with risk factors, if it is not detected and treated appropriately. This study evaluated the sensitivity and specificity of an automatic oscillometric sphygmomanometer designed to detect AF.

Methods 
The sphygmomanometer incorporates an algorithm for detecting AF while reducing false positive readings due to premature beats. A total of 405 unselected outpatients seen in two cardiology offices were evaluated by taking three sequential device readings and one electrocardiogram (EKG) on each patient.

Results
For detecting AF, the sensitivity was 95% and the specificity 86% with a positive predictive value of 68% and a negative predictive value of 98% for single device readings. For the three sequential device readings grouped together, the sensitivity was 97% and the specificity was 89%. The device correctly categorized most of the non-AF, abnormal rhythms. The specificity for those in sinus rhythm was 97%.

Conclusions
This device is able to detect AF with high sensitivity and specificity. Use of this device by patients who monitor their blood pressure at home may help detect asymptomatic AF and allow for treatment prior to the development of a stroke.

© Am J Hypertens 2009; 22:848-852 © 2009 American Journal of Hypertension, Ltd.

Download this abstract as PDF

Click here to read this article on PubMed

Microlife
  • Contatti
  • Sede Legale
  • Privacy & Cookie Policy
  • Termini di utilizzo
  • Sviluppatori
Login
Copyright © 2025 - Microlife Corporation. All rights reserved.